• A novel and reliable RT PCR based detection method for Corona Virus (2019) infection.Patent No. 364083. Granted
• A Novel Silver nanoparticle conjugate prepared from a phytochemical extract causing preferred apoptosis in cancer cell lines and the preparation process therein. (Ind. Patent Appln. No.201711018834 /DEL/2017) Patent No. 419319 Granted.
• A cattle milk based formulation with potential for management of dengue symptoms. (Ind. Patent Appln. No.201611044471 /DEL/2016).
• A Novel formulation of Vitamins increases the immune efficiency in low birth weight newborn. IPatent No. 392096. Granted
• A Pattern Recognition Receptor (PRR) particularly a Toll-like receptor (TLR) which has a unique association with the presence of glomerulonephritis (GN) in Systemic Lupus Erythematosus (SLE)”. Patent No.376542). Granted

With a rich history of collaboration spanning across diverse sectors, our company has firmly established itself as a trusted partner in the realm of scientific exploration and innovation. Our extensive experience revolves around working closely with government bodies, semi-government organizations, local authorities, private enterprises, and the wider public to conduct comprehensive examinations, in-depth analyses, intricate investigations, pioneering experiments, and groundbreaking research initiatives. Our portfolio encompasses a wide spectrum of products and materials, ranging from pharmaceuticals, medical advancements, and biotechnology innovations to metallurgical breakthroughs, agricultural technologies, and essential industrial and domestic necessities. What sets us apart is our unwavering commitment to fostering global partnerships, bridging boundaries, and addressing critical challenges through collaborative research efforts on both national and international fronts.